![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
Background: Medication adherence is the process by which patients take their medication as prescribed and is an umbrella term that encompasses all aspects of medication use patterns. Ambiguous terminology has emerged to describe a deviation from prescribed regimen, forcing the European ABC Project to define 3 phases of medication use: initiation, implementation, and discontinuation. However, different measures of medication adherence using medication records are currently available that do not always distinguish between these phases. The literature is lacking standardization and operationalization of the assessment methods. Objective: To propose a harmonization of standards as well as definitions of distinct measures and their operationalization to quantify adherence to medication from medication records. Methods: Group discussions and consensus process among all coauthors. The propositions were generated using the authors’ experiences and views in the field of adherence, informed by theory. Results: The concepts of adherence measures within the new taxonomy were harmonized, and the standards necessary for the operationalization of adherence measures from medication records are proposed. Besides percentages and time-to values, the addition of a dichotomous value for the reinitiation of treatment is proposed. Methodological issues are listed that should be disclosed in studies on adherence. Conclusions: The possible impact of the measures in adherence research is discussed. By doing this, the results of future adherence research should gain in accuracy. Finally, studies will become more transparent, enabling comparison between studies.
References
| 1. |
Ho, PM, Rumsfeld, JS, Masoudi, FA. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836-1841. Google Scholar | Crossref | Medline |
| 2. |
Rasmussen, JN, Chong, A, Alter, DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177-186. Google Scholar | Crossref | Medline | ISI |
| 3. |
Caetano, PA, Lam, JMC, Morgan, SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther. 2006;28:1411-1424, discussion 1410. Google Scholar | Crossref | Medline | ISI |
| 4. |
Peterson, AM, Nau, DP, Cramer, JA. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10:3-12. Google Scholar | Crossref | Medline | ISI |
| 5. |
Sattler, ELP, Lee, JS, Perri, M. Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature. Drugs Aging. 2013;30:383-399. Google Scholar | Crossref | Medline | ISI |
| 6. |
Hess, LM, Raebel, MA, Conner, DA. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280-1288. Google Scholar | SAGE Journals | ISI |
| 7. |
Karve, S, Cleves, MA, Helm, M. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value Health. 2009;12:989-995. Google Scholar | Crossref | Medline | ISI |
| 8. |
Wilke, T, Groth, A, Mueller, S. How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus. Eur J Health Econ. 2013;14:551-568. Google Scholar | Crossref | Medline | ISI |
| 9. |
Laforest, L, Licaj, I, Devouassoux, G. Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease. Chron Respir Dis. 2013;10:11-18. Google Scholar | SAGE Journals | ISI |
| 10. |
Bryson, CL, Au, DH, Young, B. A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care. 2007;45:497-504. Google Scholar | Crossref | Medline | ISI |
| 11. |
Williams, AB, Amico, KR, Bova, C. A proposal for quality standards for measuring medication adherence in research. AIDS Behav. 2013;17:284-297. Google Scholar | Crossref | Medline | ISI |
| 12. |
Vrijens, B, De Geest, S, Hughes, DA. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691-705. Google Scholar | Crossref | Medline | ISI |
| 13. |
Arnet, I, Abraham, I, Messerli, M. A method for calculating adherence to polypharmacy from dispensing data records. Int J Clin Pharm. 2013;36:192-201. Google Scholar | Crossref | Medline | ISI |
| 14. |
Scheen, L, Brandt, L, Bodén, R. Predictors for initiation of pharmacological prophylaxis in patients with newly diagnosed bipolar disorder: a nationwide cohort study. J Affect Disord. 2015;172:204-210. Google Scholar | Crossref | Medline | ISI |
| 15. |
Andrade, S, Kahler, K, Frech, F. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15:565-574. Google Scholar | Crossref | Medline | ISI |
| 16. |
Balasubramanian, A, Brookhart, MA, Goli, V. Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women. Int J Gen Med. 2013;6:839-848. Google Scholar | Crossref | Medline |
| 17. |
Greevy, RA, Huizinga, MM, Roumie, CL. Comparisons of persistence and durability among three oral antidiabetic therapies using electronic prescription-fill data: the impact of adherence requirements and stockpiling. Clin Pharmacol Ther. 2011;90:813-819. Google Scholar | Crossref | Medline | ISI |
| 18. |
Kozma, C, Paris, A, Ingham, M. Quality measures and adherence: potential hazards of using administrative claims to measures biologic specialty pharmaceutical immunology product adherence when days’ supply is unspecified (conference abstract, 15th Annual European Congress of Rheumatology, Jun 11-14, 2014). Ann Rheum Dis. 2014;73:339-340. Google Scholar | Crossref |
| 19. |
Balkrishnan, R, Christensen, DB. A comparison of medication adherence indices to assess long-term inhaled corticosteroid medication use. J Asthma. 2001;38:91-98. Google Scholar | Crossref | Medline | ISI |
| 20. |
Steiner, JF, Prochazka, AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-116. Google Scholar | Crossref | Medline | ISI |
| 21. |
Leenen, F, Fourney, A, Notman, G. Persistence of anti-hypertensive effect after “missed doses” of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life. Br J Clin Pharmacol. 1996;41:83-88. Google Scholar | Crossref | Medline | ISI |
| 22. |
Geers, HCJ, Bouvy, ML, Heerdink, ER. Estimates of statin discontinuation rates are influenced by exposure and outcome definitions. Ann Pharmacother. 2011;45:576-581. Google Scholar | SAGE Journals | ISI |
| 23. |
Holkmann Olsen, C, Mocroft, A, Kirk, O. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. HIV Med. 2007;8:96-104. Google Scholar | Crossref | Medline | ISI |
| 24. |
Fox, Z, Phillips, A, Cohen, C. Viral re-suppression and detection of drug resistance following interruption of a suppressive NNRTI-based regimen. AIDS. 2008;22:2279-2289. Google Scholar | Crossref | Medline | ISI |
| 25. |
Tinago, W, O’Halloran, JA, O’Halloran, RM. Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions. HIV Med. 2014;15:224-232. Google Scholar | Crossref | Medline | ISI |
| 26. |
Moore, DM, Zhang, W, Yip, B. Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme. HIV Med. 2010;11:299-307. Google Scholar | Crossref | Medline | ISI |
| 27. |
Brookhart, M, Patrick, AR, Schneeweiss, S. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med. 2007;167:847-852. Google Scholar | Crossref | Medline |
| 28. |
Korhonen, MJ, Helin-Salmivaara, A, Huupponen, R. Dynamics of long-term statin therapy. Eur J Clin Pharmacol. 2011;67:925-931. Google Scholar | Crossref | Medline | ISI |
| 29. |
Nau, D . Proportion of days covered (PDC) as a preferred method of measuring medication adherence. http://www.pqaalliance.org/images/uploads/files/PQA%20PDC%20vs%20%20MPR.pdf. Accessed September 29, 2015. Google Scholar |
| 30. |
Martin, BC, Wiley-Exley, EK, Richards, S. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother. 2009;43:36-44. Google Scholar | SAGE Journals | ISI |
| 31. |
Lamberts, EJF, Nijpels, G, Welschen, LMC. Long term patterns of use after initiation of oral antidiabetic drug therapy. Pharmacoepidemiol Drug Saf. 2011;20:351-358. Google Scholar | Crossref | Medline | ISI |
| 32. |
Pariente, A, Fourrier-Reglat, A, Bazin, F. Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors. Neurology. 2012;78:957-963. Google Scholar | Crossref | Medline | ISI |
| 33. |
Rogers, SL, Farlow, MR, Doody, RS. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Donepezil Study Group. Neurology. 1998;50:136-145. Google Scholar | Crossref | Medline | ISI |
| 34. |
Doro, P, Benko, R, Kosik, E. Utilization of oral antihyperglycemic drugs over a 7-year period (1998-2004) in a Hungarian population and adherence to drug therapy. Eur J Clin Pharmacol. 2005;61:893-897. Google Scholar | Crossref | Medline | ISI |
| 35. |
Scott, L. Calculating medication compliance, adherence, and persistence in administrative pharmacy claims databases. Pharmaceutical Programming. 2008;1:13-19. Google Scholar | Crossref |
| 36. |
Harbig, P, Barat, I, Lund Nielsen, P. Instantaneous detection of nonadherence: quality, strength, and weakness of an electronic prescription database. Pharmacoepidemiol Drug Saf. 2012;21:323-328. Google Scholar | Crossref | Medline | ISI |
| 37. |
Department of Health and Human Services . Electronic prescribing incentive fact sheet: introduction to E-prescribing incentive. http://www.cms.gov/PQRI/Downloads/PQRIEPrescribingFactSheet.pdf. Accessed August 5, 2015. Google Scholar |
| 38. |
Joseph, SB, Sow, MJ, Furukawa, MF. E-prescribing adoption and use increased substantially following the start of a federal incentive program. Health Aff (Millwood). 2013;32:1221-1227. Google Scholar | Crossref | Medline | ISI |
